Peptide Therapeutics Enters a New Era with Quantum Computing Integration: Experts

2 months ago 1
ARTICLE AD BOX

The 5th Student IPS Symposium jointly organised by the GITAM School of Science, GITAM School of Pharmacy and the Indian Peptide Society (IPS), saw scientists, researchers and students deliberate connected emerging frontiers successful peptide science, and the expanding scope of therapeutic landscapes of peptides.

Addressing the gathering connected Thursday, Prof. K. N. Ganesh, president of IPS and elder idiosyncratic astatine the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), noted that peptide-based medicines are presently employed successful the absorption and diagnosis of a wide spectrum of aesculapian conditions, including diabetes mellitus, obesity and value management, oncology, and respective uncommon diseases.

Prof. Ganesh emphasised that peptides are gaining important attraction successful the improvement of targeted cause transportation systems and next-generation peptide-based vaccines.

Peptide cause find is undergoing a technological gyration by merging with quantum computing, enabling the plan of analyzable therapeutic peptides with unprecedented precision and speed, helium stated. He further pointed to emerging innovation hubs specified arsenic Amaravati Quantum Valley, which purpose to alteration cause find done precocious quantum algorithms for molecular simulation and accelerated therapeutic design.

Prof. L. Srinivas, main GITAM School of Pharmacy, elaborated connected the advantages of peptide-based cause transportation systems implicit accepted synthetic systems. He besides noted that astir 100 peptide drugs person already received planetary approval, with respective candidates progressing from preclinical stages to objective trials, underscoring the dependable maturation of the planetary peptide therapeutics market.

Published - February 26, 2026 06:52 p.m. IST

Read Entire Article